Norway
· Delayed Price · Currency is NOK Arctic Bioscience AS Statistics
Total Valuation
OSL:ABS has a market cap or net worth of NOK 69.39 million. The enterprise value is 67.59 million.
| Market Cap | 69.39M |
| Enterprise Value | 67.59M |
Important Dates
The last earnings date was Wednesday, May 7, 2025.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OSL:ABS has 26.69 million shares outstanding. The number of shares has decreased by -0.26% in one year.
| Current Share Class | 26.69M |
| Shares Outstanding | 26.69M |
| Shares Change (YoY) | -0.26% |
| Shares Change (QoQ) | -0.22% |
| Owned by Insiders (%) | 17.86% |
| Owned by Institutions (%) | 11.56% |
| Float | 12.99M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.56 |
| PB Ratio | 0.33 |
| P/TBV Ratio | 0.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.41 |
| EV / Sales | 1.52 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.70 |
Financial Position
The company has a current ratio of 0.86, with a Debt / Equity ratio of 0.01.
| Current Ratio | 0.86 |
| Quick Ratio | 0.43 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.02 |
| Interest Coverage | -15.18 |
Financial Efficiency
Return on equity (ROE) is -20.43% and return on invested capital (ROIC) is -12.63%.
| Return on Equity (ROE) | -20.43% |
| Return on Assets (ROA) | -10.30% |
| Return on Invested Capital (ROIC) | -12.63% |
| Return on Capital Employed (ROCE) | -22.52% |
| Revenue Per Employee | 2.61M |
| Profits Per Employee | -2.82M |
| Employee Count | 355 |
| Asset Turnover | 0.15 |
| Inventory Turnover | 1.02 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.00% in the last 52 weeks. The beta is 1.39, so OSL:ABS's price volatility has been higher than the market average.
| Beta (5Y) | 1.39 |
| 52-Week Price Change | -75.00% |
| 50-Day Moving Average | 4.28 |
| 200-Day Moving Average | 6.01 |
| Relative Strength Index (RSI) | 31.30 |
| Average Volume (20 Days) | 81,370 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, OSL:ABS had revenue of NOK 44.40 million and -47.93 million in losses. Loss per share was -1.89.
| Revenue | 44.40M |
| Gross Profit | 12.81M |
| Operating Income | -47.79M |
| Pretax Income | -47.93M |
| Net Income | -47.93M |
| EBITDA | -42.64M |
| EBIT | -47.79M |
| Loss Per Share | -1.89 |
Balance Sheet
The company has 3.28 million in cash and 1.47 million in debt, giving a net cash position of 1.80 million or 0.07 per share.
| Cash & Cash Equivalents | 3.28M |
| Total Debt | 1.47M |
| Net Cash | 1.80M |
| Net Cash Per Share | 0.07 |
| Equity (Book Value) | 210.73M |
| Book Value Per Share | 8.28 |
| Working Capital | -9.65M |
Cash Flow
In the last 12 months, operating cash flow was -45.36 million and capital expenditures -50.81 million, giving a free cash flow of -96.17 million.
| Operating Cash Flow | -45.36M |
| Capital Expenditures | -50.81M |
| Free Cash Flow | -96.17M |
| FCF Per Share | -3.60 |
Margins
Gross margin is 28.84%, with operating and profit margins of -107.62% and -107.95%.
| Gross Margin | 28.84% |
| Operating Margin | -107.62% |
| Pretax Margin | -107.95% |
| Profit Margin | -107.95% |
| EBITDA Margin | -96.02% |
| EBIT Margin | -107.62% |
| FCF Margin | n/a |
Dividends & Yields
OSL:ABS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.26% |
| Shareholder Yield | 0.26% |
| Earnings Yield | -69.08% |
| FCF Yield | -138.59% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |